UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Nitric oxide donors : Novel cancer therapeutics (Review)

International journal of oncology, 2008-11, Vol.33 (5), p.909-927

2008

Volltextzugriff (PDF)

Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review

International Journal of Molecular Sciences, 2012-12, Vol.13 (12), p.17244-17274

Qandil, Amjad M

2012

Volltextzugriff (PDF)

NO‐sulindac inhibits the hypoxia response of PC‐3 prostate cancer cells via the Akt signalling pathway

International journal of cancer, 2009-01, Vol.124 (1), p.223-232

2009

Volltextzugriff (PDF)

Effects of nitro-butoxyl- and butyl-esters of non-steroidal anti-inflammatory drugs compared with parent compounds on the contractility of digital arterial smooth muscle from the fallow deer (Dama dama)

Inflammopharmacology, 2021-10, Vol.29 (5), p.1459-1473

2021

Volltextzugriff (PDF)

Gastric-sparing nitric oxide-releasable 'true' prodrugs of aspirin and naproxen

Bioorganic & medicinal chemistry letters, 2014-12, Vol.24 (24), p.5587-5592

2014

Volltextzugriff (PDF)

Nitric oxide donor hybrid compounds as promising anticancer agents

Drug Discoveries & Therapeutics, 2016, Vol.10(6), pp.276-284

2016

Volltextzugriff (PDF)

Antinociceptive effects of NCX‐701 (nitro‐paracetamol) in neuropathic rats: enhancement of antinociception by co‐administration with gabapentin

British journal of pharmacology, 2009-09, Vol.158 (2), p.601-609

2009

Volltextzugriff (PDF)

Nitric oxide–releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets

Molecular cancer therapeutics, 2006-06, Vol.5 (6), p.1530-1538

2006

Volltextzugriff (PDF)

NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S -nitrosylation

Cancer letters, 2010-12, Vol.298 (2), p.204-211

2010

Volltextzugriff (PDF)

Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo

Molecules (Basel, Switzerland), 2015-07, Vol.20 (7), p.12481-12499

2015

Volltextzugriff (PDF)

NO-donating NSAIDs and cancer: An overview with a note on whether NO is required for their action

Nitric oxide, 2008-09, Vol.19 (2), p.199-204

2008

Volltextzugriff (PDF)

The mechanism of action of nitric oxide-donating aspirin

Biochemical and biophysical research communications, 2007-07, Vol.358 (4), p.1096-1101

2007

Volltextzugriff (PDF)

Current approaches to prevent NSAID‐induced gastropathy – COX selectivity and beyond

British journal of clinical pharmacology, 2004-12, Vol.58 (6), p.587-600

2004

Volltextzugriff (PDF)

Synthesis of thiophene and NO-curcuminoids for antiinflammatory and anti-cancer activities

Molecules (Basel, Switzerland), 2013-01, Vol.18 (2), p.1483-1501

2013

Volltextzugriff (PDF)

Anti-Inflammatory Agents as Cancer Therapeutics

Advances in Pharmacology, 2009, Vol.57, p.31-89

Kashfi, Khosrow

2009

Volltextzugriff (PDF)

NO-NSAIDs: Gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs

Bioorganic & medicinal chemistry letters, 2009-09, Vol.19 (18), p.5297-5301

2009

Volltextzugriff (PDF)

Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans

Bioorganic & medicinal chemistry, 2011-10, Vol.19 (19), p.5852-5860

2011

Volltextzugriff (PDF)

Management of NSAID/aspirin-induced small intestinal damage by GI-sparing NSAIDs, anti-ulcer drugs and food constituents

Current medicinal chemistry, 2012, Vol.19 (1), p.82

2012

Volltextzugriff (PDF)

Relaxation induced by the nitric oxide donor and cyclooxygenase inhibitor NCX2121 in renal hypertensive rat aortas

European journal of pharmaceutical sciences, 2017-09, Vol.107, p.45-53

2017

Volltextzugriff (PDF)

NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?

Biochemical pharmacology, 2004-06, Vol.67 (12), p.2197-2205

2004

Volltextzugriff (PDF)

Multitarget drugs: Focus on the NO-donor hybrid drugs

Pure and applied chemistry, 2008-08, Vol.80 (8), p.1693-1701

2008

Volltextzugriff (PDF)

Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling

Cancer letters, 2009-01, Vol.273 (2), p.292-299

2009

Volltextzugriff (PDF)

Synthesis of novel 4-substituted-7-trifluoromethylquinoline derivatives with nitric oxide releasing properties and their evaluation as analgesic and anti-inflammatory agents

Bioorganic & medicinal chemistry, 2005-10, Vol.13 (20), p.5759-5765

2005

Volltextzugriff (PDF)

Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity

Neurobiology of aging, 2002-09, Vol.23 (5), p.787-794

2002

Volltextzugriff (PDF)

Novel agents for cancer prevention based on nitric oxide

Biochemical Society transactions, 2007-11, Vol.35 (Pt 5), p.1364

Rigas, B

2007

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(51)
Buchkapitel
(2)

Sprache

Englisch
(53)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(44)
Humans
(36)
No-Nsaids
(36)
Animals
(29)
Anti-Inflammatory Agents, Non-Steroidal - Pharmacology
(20)
Nitric Oxide
(19)
Pharmacology & Pharmacy
(19)
Biological And Medical Sciences
(18)
Medical Sciences
(17)
Nitric Oxide - Metabolism
(16)
Male
(15)
No-Nsaid
(15)
Biochemistry & Molecular Biology
(14)
Pharmacology. Drug Treatments
(14)
Aspirin - Analogs & Derivatives
(12)
Rats
(12)
Anti-Inflammatory Agents, Non-Steroidal - Therapeutic Use
(11)
Aspirin - Pharmacology
(11)
Cell Line, Tumor
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nitric oxide donors : Novel cancer therapeutics (Review)

Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review

NO‐sulindac inhibits the hypoxia response of PC‐3 prostate cancer cells via the Akt signalling pathway

Effects of nitro-butoxyl- and butyl-esters of non-steroidal anti-inflammatory drugs compared with parent compounds on the contractility of digital arterial smooth muscle from the fallow deer (Dama dama)

Gastric-sparing nitric oxide-releasable 'true' prodrugs of aspirin and naproxen

Nitric oxide donor hybrid compounds as promising anticancer agents

Antinociceptive effects of NCX‐701 (nitro‐paracetamol) in neuropathic rats: enhancement of antinociception by co‐administration with gabapentin

Nitric oxide–releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets

NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S -nitrosylation

Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo

NO-donating NSAIDs and cancer: An overview with a note on whether NO is required for their action

The mechanism of action of nitric oxide-donating aspirin

Current approaches to prevent NSAID‐induced gastropathy – COX selectivity and beyond

Synthesis of thiophene and NO-curcuminoids for antiinflammatory and anti-cancer activities

Anti-Inflammatory Agents as Cancer Therapeutics

NO-NSAIDs: Gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs

Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans

Management of NSAID/aspirin-induced small intestinal damage by GI-sparing NSAIDs, anti-ulcer drugs and food constituents

Relaxation induced by the nitric oxide donor and cyclooxygenase inhibitor NCX2121 in renal hypertensive rat aortas

NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?

Multitarget drugs: Focus on the NO-donor hybrid drugs

Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling

Synthesis of novel 4-substituted-7-trifluoromethylquinoline derivatives with nitric oxide releasing properties and their evaluation as analgesic and anti-inflammatory agents

Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity

Novel agents for cancer prevention based on nitric oxide

Suchergebnisse filtern